Psychiatric Medication Management in FL & SC

The short answer

Psychiatric medication management at Stedfast Psychiatry means a prescriber selects a medication based on your diagnosis and history, starts at a safe dose, sees you again in two to four weeks to measure response with scales like the PHQ-9, and adjusts until symptoms remit. Visits are in person at 13 offices or by telehealth in Florida and South Carolina.

The goal is not a prescription. The goal is remission: symptoms gone or nearly gone, functioning back, side effects tolerable or absent. Reaching that takes a plan, honest follow-up and a willingness to change course when the first choice is not working. We expect to adjust, and we schedule follow-ups so adjustments happen on time rather than after months of waiting.

Who it is for

Medication management is for anyone whose evaluation points to a condition that responds to medication: depression, anxiety disorders, ADHD, bipolar disorder, OCD, PTSD, insomnia, schizophrenia and others. It is also for people already on psychiatric medication who need a prescriber to take over, review the regimen, or figure out why it stopped working.

People often come to us after a primary care physician has started an antidepressant and reached the limit of what a general practice can manage. Others have been on the same medication for ten years without anyone asking whether it is still needed. Some have tried four or five medications and are told nothing works; those patients often have an unrecognized diagnosis, an inadequate dose, or a candidate for augmentation, Deep TMS or Spravato. New patients start with a psychiatric evaluation; transfers of care can usually bring their records and continue without interruption.

If medications have not worked or caused strong side effects, ask about pharmacogenomic (genetic) testing.

How it works

Prescribing starts with the diagnosis and your history. For a first episode of depression, a generic SSRI such as sertraline or escitalopram is a reasonable first choice because it is effective, well studied and inexpensive. For depression with low energy or in a patient who has had sexual side effects on an SSRI, bupropion may be better. For ADHD, a stimulant is first line for most patients, with non-stimulants such as atomoxetine or guanfacine for those who cannot take one. For bipolar disorder, a mood stabilizer or an atypical antipsychotic comes before any antidepressant. Your provider explains why a given medication is being chosen over the alternatives.

We start at a low dose, increase in steps, and give each dose enough time to work. Antidepressants typically need four to six weeks at a therapeutic dose before response can be judged; stimulants show their effect within days. At each follow-up we repeat the relevant scale (PHQ-9, GAD-7, ASRS or others), ask about side effects, and check adherence. If a medication has had an adequate trial without adequate response, we switch, add a second agent, or reconsider the diagnosis. Pharmacogenetic testing, which looks at how your body metabolizes certain drugs, is available as an optional tool when several medications have failed or side effects are unusual; it informs choice but does not replace clinical judgment.

Some medications require monitoring. Lithium levels, kidney and thyroid tests are checked regularly. Clozapine requires blood counts on a fixed schedule. Atypical antipsychotics call for periodic weight, glucose and lipid checks. We order these, track them and tell you the results.

In the STAR*D trial, about one third of patients reached remission on the first antidepressant, and the cumulative remission rate rose to roughly 67 percent after up to four sequential treatment steps.

Source: STAR*D, National Institute of Mental Health

Roughly half of patients stop taking a newly prescribed antidepressant within the first few months, and lack of follow-up is a major driver of early discontinuation.

Source: Sansone and Sansone, Innovations in Clinical Neuroscience, 2012

Measurement-based care, in which symptom scales are repeated at each visit, produces faster and higher rates of response and remission than usual care.

Source: Guo et al., American Journal of Psychiatry, 2015

About 16 percent of US adults took a prescription medication for a mental health condition in 2020.

Source: CDC, National Center for Health Statistics

What to expect

After the evaluation, your first medication follow-up is usually two to four weeks out, sooner for ADHD or if a medication is being started that needs early checks. Follow-ups last 20 to 30 minutes. Once you are stable, visits space out to every one to three months. Patients on controlled substances are seen at least every three months, and more often while the dose is being set.

Refills are issued at visits. If you run short between appointments, request a refill through the patient portal or your pharmacy at least three business days before you run out, and we will bridge you to the next visit if your care is current. We do not refill for patients who have missed follow-ups beyond a brief bridge; staying on a medication without monitoring is not safe prescribing. Telehealth is available for most medication visits for patients in Florida and South Carolina, with the exceptions described below for controlled substances.

Benefits

Prescribing by psychiatric specialists who see these medications every day
Measured follow-up with repeated scales so decisions are based on data
Dose adjustments on schedule, not after months of waiting
Clear policies for refills and controlled substances so there are no surprises
Lab monitoring ordered and tracked for medications that need it
Direct path to Deep TMS or Spravato if medications alone are not enough

Risks and side effects

Every psychiatric medication has side effects, and part of our job is helping you weigh them. SSRIs and SNRIs commonly cause nausea, headache, sleep changes and sexual side effects, most of which ease within weeks except the sexual effects, which may persist. Stimulants can reduce appetite, raise heart rate and blood pressure, and interfere with sleep if taken late. Atypical antipsychotics can cause weight gain, sedation and metabolic changes. Mood stabilizers have drug-specific risks that we monitor with labs. Benzodiazepines carry risks of dependence, memory effects and falls, and we prescribe them sparingly and for limited periods.

All antidepressants carry an FDA boxed warning about increased suicidal thinking in patients under 25 during the first weeks of treatment; we schedule early follow-up in that age group for that reason. Stopping many medications abruptly causes discontinuation symptoms, so changes should be made with your prescriber. Tell us about every other medication and supplement you take, since interactions (for example with tramadol, triptans, or St. John's wort) can be serious.

Cost and insurance

Medication management visits are covered by most major commercial plans and Medicare as outpatient psychiatric services. Your share is the specialist copay or coinsurance after deductible. Self-pay follow-up visits are billed at a flat rate lower than the $185 new-patient visit; ask our front desk for the current schedule.

The medications themselves are billed through your pharmacy benefit. We prescribe generics whenever a generic is clinically equivalent, which keeps most prescriptions in the lowest copay tier. Some brand-name or newer medications require prior authorization from your insurer; we handle those requests and will suggest an alternative if a request is denied. Pharmacogenetic testing is optional and may or may not be covered depending on your plan; we tell you the expected cost before ordering it. Lab monitoring is billed by the laboratory and is usually covered as routine testing.

How we choose a medication

No single drug is best for everyone. The choice depends on the diagnosis, the specific symptoms that bother you most, what you have taken before, other medical conditions, other medications, pregnancy plans, cost and your own preferences. A patient with depression who cannot sleep may do better on a sedating option taken at night; a patient with depression who cannot get out of bed may do better on an activating one. A patient who gained weight on one antipsychotic deserves one with a lower metabolic burden.

We lean on treatment guidelines from the American Psychiatric Association and on large comparative trials, and we tell you where the evidence is strong and where it is thin. For most first-line decisions the differences between options are modest and tolerability decides. For second- and third-line decisions, history matters more: a close relative who responded well to a given antidepressant is a real, if imperfect, signal.

Adequate trials and when to change

A common reason people believe "nothing works" is that nothing was given a fair trial. An adequate antidepressant trial is a therapeutic dose for at least four to six weeks; a trial cut short at two weeks on a starting dose tells us little. We set expectations at the start, raise the dose on schedule, and measure. If the scale has not moved by a meaningful amount at the adequate point, we act. Waiting another three months hoping is not a plan.

Controlled substances in Florida and South Carolina

Stimulants (Schedule II) and benzodiazepines (Schedule IV) are regulated by federal and state law, and our policies follow those rules. Before any controlled prescription we check the state prescription drug monitoring program, which is required by law in both states. Florida limits most controlled substance prescriptions to a defined supply and requires that Schedule II medications prescribed by telehealth follow specific in-person requirements. South Carolina has its own telemedicine statute with similar limits. Federal flexibilities that allowed telehealth prescribing of controlled substances during the public health emergency have been extended several times; we follow whatever rule is in force on the date of your visit and will tell you if an in-person visit is required.

We ask patients on controlled substances to use one pharmacy, to keep follow-up appointments, and to let us know about any other sedating medications. Lost or stolen prescriptions are not routinely replaced early. These policies exist to protect you and to keep our prescribing defensible, which in turn keeps us able to prescribe for the patients who need these medications.

Stopping a medication

When it is time to stop, we taper. SSRIs, SNRIs and benzodiazepines in particular cause discontinuation symptoms if stopped abruptly: dizziness, nausea, irritability, electric-shock sensations, rebound anxiety or insomnia. A taper over weeks, sometimes months for benzodiazepines, avoids most of that. If you want to stop a medication, tell us and we will plan it with you rather than have you stop on your own and feel worse.

Coordination with therapy and other doctors

Medication works better with therapy for most conditions, and we say so. If you see a therapist, in our practice or elsewhere, we coordinate with your permission. We also send a summary to your primary care physician so that everyone prescribing for you sees the whole picture. Drug interactions are a real risk when several clinicians are writing prescriptions without talking to each other.

Frequently asked questions

How often will I need to be seen?

Every two to four weeks while a medication is being started or adjusted, then every one to three months once you are stable. Patients on stimulants or other controlled substances are seen at least every three months by policy. Follow-up visits run 20 to 30 minutes. If something changes between visits, message us through the portal; we can often add a short visit rather than wait.

Can I get my prescriptions through telehealth?

Most non-controlled medications, yes, for patients physically in Florida or South Carolina at the time of the visit. Controlled substances are more restricted. Federal rules currently allow telehealth prescribing of controlled substances under temporary flexibilities, and Florida law requires an in-person examination before Schedule II medications such as stimulants are prescribed by telehealth, with limited exceptions. We will tell you at scheduling which visits must be in the office.

What is your policy on stimulants and benzodiazepines?

We prescribe them when they are the right treatment and we prescribe them carefully. Stimulants require a completed ADHD evaluation, a check of the state prescription monitoring database (E-FORCSE in Florida, SCRIPTS in South Carolina), and follow-up at least every three months. Benzodiazepines are generally used short term or as a bridge while a longer-term treatment takes effect, not as a primary long-term anxiety medication. Early refills for lost or stolen controlled prescriptions are not routine.

How do refills work?

Refills are written at your visits to carry you to the next appointment. If you need one between visits, request it through the patient portal or ask your pharmacy to send a request, at least three business days before you run out. If your care is current we will bridge you. If you have missed follow-ups, we will schedule a visit before refilling, because prescribing without monitoring is not safe.

Should I get genetic testing for my medications?

It is optional and most patients do not need it. Pharmacogenetic tests look at genes that affect how you metabolize certain drugs and can explain unusual side effects or repeated failures. They do not say which medication will work. We suggest it mainly when two or more medications have failed or produced unexpected reactions. Coverage varies; we tell you the expected cost first.

How long will I need to take medication?

It depends on the condition and your history. A first episode of depression is usually treated for 6 to 12 months after remission before a gradual taper is considered. Recurrent depression, bipolar disorder and schizophrenia often call for long-term treatment. ADHD medication is taken as long as it helps. We review the question at follow-ups rather than leaving you on something indefinitely by default.

What if my medication stops working?

Tell us, and we will look at dose, adherence, new stressors, substance use, thyroid function and whether the diagnosis still fits. Options include raising the dose, switching, adding an augmenting agent, or adding therapy. For depression that has not responded to two or more adequate trials, Deep TMS and Spravato are both available within the practice.

Can my primary care doctor keep prescribing instead?

Sometimes. If you reach a stable regimen on a single non-controlled medication, we are glad to hand prescribing back to your primary care physician with a summary letter. Complex regimens, controlled substances, mood stabilizers and antipsychotics are usually better managed by a psychiatric prescriber.

Where this treatment is offered

Conditions this treats

Major Depressive Disorder Generalized Anxiety Disorder ADHD in Adults and Children Bipolar Disorder Obsessive-Compulsive Disorder Post-Traumatic Stress Disorder Insomnia Schizophrenia and Psychotic Disorders Treatment-Resistant Depression Panic Disorder

If you are in crisis, call or text 988 or go to the nearest emergency room. Educational content; individual results vary. Reviewed by Dr. David Husted, board-certified psychiatrist.

Psychiatric Medication Management